DIMENSIONAL FUND ADVISORS LP - CRINETICS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$22,150,134
+136.8%
744,816
+43.5%
0.01%
+133.3%
Q2 2023$9,353,979
+29.6%
519,109
+15.5%
0.00%
+50.0%
Q1 2023$7,220,275
+77445.6%
449,605
-11.6%
0.00%
-33.3%
Q4 2022$9,311
-99.9%
508,848
-5.1%
0.00%
-25.0%
Q3 2022$10,528,000
+1.9%
536,070
-3.2%
0.00%0.0%
Q2 2022$10,329,000
-3.8%
553,871
+13.2%
0.00%
+33.3%
Q1 2022$10,736,000
+9.4%
489,357
+41.7%
0.00%0.0%
Q4 2021$9,814,000
+49.7%
345,444
+11.0%
0.00%
+50.0%
Q3 2021$6,554,000
+87.6%
311,344
+68.0%
0.00%
+100.0%
Q2 2021$3,493,000
+247.9%
185,293
+181.9%
0.00%
Q1 2021$1,004,000
+197.9%
65,720
+175.0%
0.00%
Q4 2020$337,00023,8950.00%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 820,720$17,276,0007.15%
5AM Venture Management, LLC 1,362,286$28,676,0005.82%
Bain Capital Life Sciences Investors, LLC 1,679,701$35,358,0002.19%
Opaleye Management Inc. 402,113$8,464,0001.58%
FRAZIER MANAGEMENT LLC 851,306$17,920,0001.43%
Perceptive Advisors 3,963,517$83,432,0001.21%
Altium Capital Management LP 193,000$4,063,0001.07%
MPM BioImpact LLC 298,392$6,281,0000.97%
SPHERA FUNDS MANAGEMENT LTD. 548,643$11,549,0000.97%
Ghost Tree Capital, LLC 150,000$3,158,0000.92%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders